🔎 Trials Near Me

Utama › Sarkoma Ewing › Ohio

Kajian klinikal Sarkoma Ewing di Ohio

8 kajian untuk Sarkoma Ewing sedang mencari peserta di lokasi di Ohio.

Bandar di Ohio

Teks kajian rasmi (Bahasa Inggeris)

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

  • Cleveland Clinic Children's, Cleveland
  • Nationwide Children's Hospital, Columbus
Mengambil pesertaFasa 1
Umur 1 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07194044

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Mengambil pesertaFasa 1
Umur 12 hingga 85 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT03715933

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Mengambil pesertaFasa 1/2
12 Months – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04851119

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

  • Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT05210374

Single Arm Romiplostim to Prevent CIT

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Mengambil pesertaFasa awal 1
Umur 1 ke atas · Semua jantina · Dikemas kini 18 Mac 2026 · NCT07048249

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

  • The Ohio State University Wexner Medical Center, Columbus
Mengambil peserta
Umur 13 ke atas · Semua jantina · Dikemas kini 6 Feb 2026 · NCT06387485

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
Mengambil pesertaFasa 1/2
Umur 2 hingga 30 · Semua jantina · Dikemas kini 3 Feb 2026 · NCT05734066

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Nationwide Children's Hospital, Columbus
Mengambil pesertaFasa 2
18 Months – 40 Years · Semua jantina · Dikemas kini 12 Ogo 2025 · NCT05135975

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.